1B-LSD explained
1B-LSD (N1-butyryl-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug.[1] In tests on mice it was found to be an active psychedelic, though with only around 1/7 the potency of LSD itself.[2] [3] [4]
Legal status
1B-LSD is illegal in Singapore.[5] Sweden's public health agency suggested classifying 1B-LSD as a hazardous substance, on June 24, 2019.[6]
See also
References
Notes and References
- Tsochatzis E, Lopes JA, Reniero F, Holland M, Åberg J, Guillou C . Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics . Molecules . 25 . 3 . 712 . February 2020 . 32045999 . 7037844 . 10.3390/molecules25030712 . free .
- 6 . Wagmann L, Richter LH, Kehl T, Wack F, Bergstrand MP, Brandt SD, Stratford A, Maurer HH, Meyer MR . July 2019 . In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures . . 411 . 19 . 4751–4763 . 10.1007/s00216-018-1558-9 . 30617391 . 58615418.
- 6 . Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Dowling G, Wallach J, Halberstadt AL . August 2019 . Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD) . . 11 . 8 . 1122–1133 . 10.1002/dta.2613 . 6899222 . 31083768.
- Halberstadt AL, Chatha M, Klein AK, McCorvy JD, Meyer MR, Wagmann L, Stratford A, Brandt SD . 6 . Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD) . Neuropharmacology . 172 . 107856 . August 2020 . 31756337 . 10.1016/j.neuropharm.2019.107856 . 9191647 . 208155327 .
- Web site: Misuse of Drugs Act - Singapore Statutes Online. sso.agc.gov.sg.
- Web site: Åtta ämnen föreslås klassas som narkotika eller hälsofarlig vara . Folkhälsomyndigheten . sv . 24 June 2019 .
